Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | PKM | P14618 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | PRKAG1 | P54619 | 3/20 | 0.33 |
| ▸ | PRKAA2 | P54646 | 3/20 | 0.33 |
| ▸ | PRKAB1 | Q9Y478 | 3/20 | 0.33 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13170506 | 0.92 | MAPT (0.37) | MAPTPKMALDH1A1MAPK1NPSR1 | |
| SCHEMBL12316234 | 0.88 | KCNH2 (0.35) | MAPTPKMALDH1A1MAPK1NPSR1 | |
| SCHEMBL13241434 | 0.83 | POLB (0.37) | MAPTPKMALDH1A1MAPK1NPSR1 | |
| SCHEMBL16939105 | 0.79 | MAPT (0.38) | MAPTPKMALDH1A1MAPK1NPSR1 | |
| SCHEMBL16705068 | 0.79 | POLB (0.34) | MAPTPKMALDH1A1MAPK1NPSR1 | |
| SCHEMBL10014704 | 0.79 | MAPT (0.40) | MAPTPKMALDH1A1MAPK1NPSR1 | |
| SCHEMBL13160779 | 0.79 | MAPT (0.35) | MAPTPKMALDH1A1MAPK1NPSR1 | |
| SCHEMBL12716312 | 0.78 | MAPT (0.39) | MAPTPKMALDH1A1MAPK1NPSR1 | |
| SCHEMBL16704756 | 0.77 | ALDH1A1 (0.35) | MAPTPKMALDH1A1MAPK1NPSR1 | |
| SCHEMBL12716317 | 0.77 | ALDH1A1 (0.34) | MAPTPKMALDH1A1MAPK1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7923214-B2 | Nonseparation assay methods | BECKMAN COULTER, INC. (US) | 2011-04-12 | — | — | US | disclosed |
| US-20110009293-A1 | Nonseparation Assay Methods | BECKMAN COULTER, INC. (US) | 2011-01-13 | — | — | US | disclosed |
| US-7799534-B2 | Nonseparation assay methods | BECKMAN COULTER, INC. (US) | 2010-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009293-A1 | Nonseparation Assay Methods | FCER2, NTRK1, FCGR2A | MAPT 4841/4885PKM 4495/4885ALDH1A1 3101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.